Martina Canichella

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Robin Foà, Renato Bassan, Antonella Vitale et al. · New England Journal of Medicine · 2020 · 467 citations · Full text

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Sabina Chiaretti, Monica Messina, Irene Della Starza et al. · Haematologica · 2020 · 78 citations · Full text

Poor Outcome, Mixed-phenotype Acute Leukemia, Immunology +16

Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial

Sabina Chiaretti, Renato Bassan, Antonella Vitale et al. · Blood · 2019 · 39 citations

Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase <scp>II</scp> pediatric‐like <scp>GIMEMA LAL</scp>‐1308 trial

Anna Maria Testi, Martina Canichella, Antonella Vitale et al. · American Journal of Hematology · 2020 · 35 citations · Full text

Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia‐positive acute lymphoblastic leukaemia

Michela Ansuinelli, Irene Della Starza, Loredana Elia et al. · Hematological Oncology · 2021 · 18 citations · Full text

Engineering, Diagnosis, Pathology +18